Alfavision Overseas (India) Limited (ALFAVIO.BO)
INR 14.4
(0.84%)
INR 14.4
(0.84%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.35 Billion INR | -13.33% |
| 2022 | 1.56 Billion INR | 21.08% |
| 2021 | 1.29 Billion INR | 432.28% |
| 2020 | 242.85 Million INR | 21.3% |
| 2019 | 200.2 Million INR | 294.0% |
| 2018 | 50.81 Million INR | -2.17% |
| 2017 | 51.93 Million INR | 672.2% |
| 2016 | 6.72 Million INR | -4.24% |
| 2015 | 7.02 Million INR | -63.51% |
| 2014 | 19.24 Million INR | -44.59% |
| 2013 | 34.74 Million INR | 4.49% |
| 2012 | 33.24 Million INR | 75.92% |
| 2011 | 18.9 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.25 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 1.35 Billion INR | 0.0% |
| 2023 FY | 1.35 Billion INR | -13.33% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 1.56 Billion INR | 21.08% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 1.56 Billion INR | 0.0% |
| 2022 Q2 | 1.2 Billion INR | 0.0% |
| 2021 Q2 | 499.26 Million INR | 0.0% |
| 2021 FY | 1.29 Billion INR | 432.28% |
| 2021 Q4 | 1.29 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 199.64 Million INR | 0.0% |
| 2020 FY | 242.85 Million INR | 21.3% |
| 2020 Q4 | 233.78 Million INR | 0.0% |
| 2019 Q2 | 1.04 Million INR | 0.0% |
| 2019 FY | 200.2 Million INR | 294.0% |
| 2019 Q4 | 200.2 Million INR | 0.0% |
| 2018 Q4 | 50.81 Million INR | 0.0% |
| 2018 Q2 | 252.85 Million INR | 0.0% |
| 2018 FY | 50.81 Million INR | -2.17% |
| 2017 Q3 | 43.3 Million INR | 376.4% |
| 2017 Q2 | 9.08 Million INR | -3.29% |
| 2017 Q1 | 9.39 Million INR | 39.73% |
| 2017 FY | 51.93 Million INR | 672.2% |
| 2017 Q4 | 51.93 Million INR | 19.95% |
| 2016 FY | 6.72 Million INR | -4.24% |
| 2016 Q4 | 6.72 Million INR | -86.08% |
| 2016 Q3 | 48.33 Million INR | 126.15% |
| 2016 Q2 | 21.37 Million INR | -0.89% |
| 2016 Q1 | 21.56 Million INR | 207.02% |
| 2015 Q2 | 39.17 Million INR | -2.44% |
| 2015 FY | 7.02 Million INR | -63.51% |
| 2015 Q1 | 40.14 Million INR | 108.58% |
| 2015 Q4 | 7.02 Million INR | -82.07% |
| 2015 Q3 | 39.17 Million INR | 0.0% |
| 2014 Q1 | 29.13 Million INR | -16.13% |
| 2014 FY | 19.24 Million INR | -44.59% |
| 2014 Q4 | 19.24 Million INR | -37.48% |
| 2014 Q3 | 30.78 Million INR | -13.11% |
| 2014 Q2 | 35.43 Million INR | 21.61% |
| 2013 Q3 | 33.24 Million INR | 0.0% |
| 2013 Q4 | 34.74 Million INR | 4.49% |
| 2013 Q1 | 33.24 Million INR | 0.0% |
| 2013 FY | 34.74 Million INR | 4.49% |
| 2013 Q2 | 33.24 Million INR | 0.0% |
| 2012 FY | 33.24 Million INR | 75.92% |
| 2012 Q4 | 33.24 Million INR | 72.73% |
| 2012 Q3 | 19.24 Million INR | 0.0% |
| 2011 FY | 18.9 Million INR | 0.0% |
| 2011 Q4 | 18.9 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Biocon Limited | 129.32 Billion INR | 98.951% |
| Blue Jet Healthcare Limited | 3.79 Million INR | -35691.319% |
| Concord Biotech Limited | 18.87 Million INR | -7088.612% |
| Dishman Carbogen Amcis Limited | 2.45 Billion INR | 44.771% |
| FERMENTA BIOTECH LIMITED | 425.36 Million INR | -218.904% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Lyka Labs Limited | 429.06 Million INR | -216.149% |
| Panacea Biotec Limited | 209.9 Million INR | -546.256% |
| SAMSRITA LABS LIMITED | - INR | -Infinity% |
| Servoteach Industries Limited | 5059.00 INR | -26813321.625% |
| SMS Lifesciences India Limited | 331.45 Million INR | -309.26% |
| Supriya Lifescience Limited | 50.2 Million INR | -2602.173% |
| Syngene International Limited | 1 Billion INR | -35.649% |
| TAKE Solutions Limited | 7.5 Million INR | -17986.547% |
| Titan Biotech Limited | 4.53 Million INR | -29824.796% |
| Transgene Biotek Limited | 50.79 Million INR | -2570.521% |
| Vanta Bioscience Limited | 488.01 Million INR | -177.961% |